CBD reduced the rewarding effects of cocaine in rats through CB2, serotonin, and TRPV1 receptors | Research

The takeaway

CBD dose-dependently reduced cocaine self-administration and cocaine-enhanced brain reward in rats by blocking cocaine-induced dopamine increases in the nucleus accumbens, working through CB2, 5-HT1A, and TRPV1 receptors.

Addiction researchers, pharmacologists studying CBD mechanisms, and clinicians interested in novel cocaine treatments.

CBD blocked cocaine-induced dopamine via CB2, 5-HT1A, and TRPV1

What the researchers found

CBD (10-40 mg/kg) reduced cocaine self-administration, shifted the cocaine dose-response curve downward, and lowered break-points for cocaine seeking. CBD also attenuated cocaine-enhanced brain stimulation reward. These effects were blocked by CB2, 5-HT1A, and TRPV1 antagonists but not by CB1, GPR55, or opioid receptor antagonists.

Why it matters

No FDA-approved medication exists for cocaine use disorder. This study identifies specific receptor mechanisms through which CBD reduces cocaine reward, providing a roadmap for clinical development.

The numbers in context

CBD doses: 10-40 mg/kg for self-administration, 3-20 mg/kg for brain stimulation reward. CBD blocked cocaine-induced dopamine increases in the nucleus accumbens. Effects mediated by CB2, 5-HT1A, and TRPV1, not CB1 or opioid receptors.

How the study worked

Rat study using intravenous cocaine self-administration, progressive-ratio reinforcement schedules, intracranial brain-stimulation reward, and in vivo microdialysis to measure dopamine levels in the nucleus accumbens.

What this study cannot tell us

Animal study results may not translate directly to humans. CBD was effective against lower cocaine doses but not high doses, suggesting it may not help the most severe cases. The specific receptor interactions need verification in humans.

How to read the evidence

Preliminary: animal study with detailed mechanistic analysis, but not yet tested in humans.

When this study was published

Published in 2020 in Neuropharmacology.

The bigger picture

The finding that CBD acts through CB2 rather than CB1 receptors is significant because CB1 drugs often produce unwanted psychoactive effects, while CB2-targeted approaches may avoid this problem.

Questions still open

Would CBD reduce cocaine craving and relapse in human clinical trials? Why was CBD ineffective against high cocaine doses? Could combination therapies targeting multiple receptor pathways improve efficacy?

Common questions

How does CBD reduce cocaine reward?

CBD appears to dampen the dopamine surge that cocaine produces in the brain's reward center (nucleus accumbens). Without this dopamine spike, cocaine becomes less rewarding. CBD achieves this through CB2, serotonin, and TRPV1 receptors.

Could this lead to a treatment for cocaine addiction?

Potentially, but significant hurdles remain. CBD only reduced self-administration of lower cocaine doses, and these are animal results. Human clinical trials would be needed to determine if CBD could help people reduce cocaine use.

Read the original research

Cannabidiol attenuates the rewarding effects of cocaine in rats by CB2, 5-HT1A and TRPV1 receptor mechanisms.

Neuropharmacology, 167, 107740

View on PubMed ↗Publisher’s paper ↗

Citation

Galaj, Ewa; Bi, Guo-Hua; Yang, Hong-Ju; Xi, Zheng-Xiong. (2020). Cannabidiol attenuates the rewarding effects of cocaine in rats by CB2, 5-HT1A and TRPV1 receptor mechanisms.. Neuropharmacology, 167, 107740. https://doi.org/10.1016/j.neuropharm.2019.107740